课题基金 / 基金详情

Cytisine: testing its potential as a therapeutic strategy for smoking cessation in subjects with concurrent alcohol use disorder

Cytisine: testing its potential as a therapeutic strategy for smoking cessation in subjects with concurrent alcohol use disorder
金雀花碱：测试其作为并发酒精使用障碍受试者戒烟治疗策略的潜力
批准号：
460540
负责人：
Le Foll Bernard
金额：
$7.14万
依托单位：
Centre for Addiction and Mental Health (Toronto)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-09-01 至 2022-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=460540&lang=en
关键词：
Cancer

项目摘要

项目成果

Le Foll Bernard的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Need for project First-line pharmacotherapies for nicotine dependence yield short-term smoking cessation efficacy but relapse remains high. This is further complicated by the fact that relapse is higher among those with concurrent alcohol use disorder. Pe
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pilot Clinical Study: Psilocybin Assisted Psychotherapy as a Novel Treatment for Comorbid Major Depressive Disorder (MDD) and Alcohol Use Disorder (AUD).
The collateral effects of COVID-19 public health policies: Perspectives of people who use opioids and those closest to them using a patient-oriented research approach
Using ECHO to Address the Needs of Francophone Addiction Service Providers in Ontario
Understanding Cannabis Use and Perceptions in Patients with Substance Use Disorders and Concurrent Disorders
海外基金